Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06885177 · ClinicalTrials.gov registry record · NA

TECTONIC CAD IVL IDE Study

A NA study of Coronary Artery Disease and Coronary Artery Calcification, sponsored by Abbott Medical Devices.

Recruiting
Registry status
NA
Development phase
335
Enrollment target
20
Study locations

NCT06885177 is a NA study of Coronary Artery Disease and Coronary Artery Calcification that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 335 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06885177, a NA study of Coronary Artery Disease and Coronary Artery Calcification, is actively recruiting participants, sponsored by Abbott Medical Devices.

RECRUITING
Registry status
NA
Development phase
335 participants
Enrollment target
20
Study locations

Study Summary

A prospective, single-arm, open-label, multi-center IDE study with up to 55 US sites

Conditions Studied

Coronary Artery Disease Coronary Artery Calcification Stenotic Coronary Lesion

Interventions

  • DEVICE Experimental

Study Locations (20)

Florida

  • The Cardiac & Vascular Institute Research Foundation, LLC - Gainesville
  • UF Health Jacksonville - Jacksonville
  • Mayo Clinic of Jacksonville - Jacksonville
  • First Coast Cardiovascular Institute - Jacksonville
  • Mt. Sinai Medical Center - Miami Beach
  • AdventHealth Orlando - Orlando
  • University of South Florida - Tampa
  • AdventHealth Tampa - Tampa

Georgia

  • Piedmont Heart Institute - Atlanta
  • Emory University Hospital - Atlanta
  • Wellstar Kennestone Regional Medical Center - Marietta

Illinois

  • Northwestern Memorial Hospital - Chicago
  • Endeavor Health - Evanston
  • Carle Foundation Hospital - Urbana

Arizona

  • HonorHealth - Scottsdale

Arkansas

  • Arkansas Heart Hospital - Little Rock

California

  • Kaiser Permanente - San Francisco - San Francisco

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Kansas

  • Via Christi Regional Medical Center - St. Francis Campus - Wichita

Trial Details

FieldValue
Enrollment Target 335 participants
Start Date 2025-04-01
Est. Completion 2028-06
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06885177

The ClinicalTrials.gov registry entry for NCT06885177 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 335 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (74% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Experimental is the first listed.

NCT06885177 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Florida, Georgia, Illinois.

Frequently Asked Questions

What is clinical trial NCT06885177 about?

NCT06885177 is a clinical study titled "TECTONIC CAD IVL IDE Study". A prospective, single-arm, open-label, multi-center IDE study with up to 55 US sites

What is the current status of trial NCT06885177?

This trial is currently recruiting. It is a NA study. The enrollment target is 335 participants. The study started on 2025-04-01. Estimated completion is 2028-06.

What conditions does trial NCT06885177 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Coronary Artery Calcification, Stenotic Coronary Lesion.

What interventions are being tested in trial NCT06885177?

The interventions under investigation include: Experimental (DEVICE).

Who is sponsoring clinical trial NCT06885177?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06885177 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Coronary Artery Calcification

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.